We’re excited to welcome Flavia Pease as our new Chief Financial Officer! Flavia is a seasoned financial leader with nearly 30 years of experience in medical technology and healthcare. She most recently served as CFO of Charles River Laboratories and spent more than two decades at Johnson & Johnson, including as Group CFO of the global Medical Devices business, where she oversaw financial operations for a $27 billion global portfolio. She has a strong track record of scaling businesses, leading global operations and driving growth in complex healthcare markets. Since joining Insulet’s Board of Directors in 2024, Flavia has been a valuable partner in shaping our strategy and has a deep understanding of our operations and financials. In connection with her appointment as CFO, she will step down from the Board upon beginning her new role. As CFO, Flavia will help guide Insulet’s next chapter of growth and innovation, strengthening our financial foundation as we continue to expand access to our life-changing technology worldwide. Please join us in welcoming Flavia to the Insulet team! #Leadership #Innovation #Insulet #DiabetesCare #Growth
About us
Insulet Corporation (NASDAQ: PODD), headquartered in Massachusetts, is an innovative medical device company dedicated to simplifying life for people with diabetes and other conditions through its Omnipod product platform. The Omnipod Insulin Management System provides a unique alternative to traditional insulin delivery methods. With its simple, wearable design, the tubeless disposable Pod provides up to three days of non-stop insulin delivery, without the need to see or handle a needle. Insulet’s flagship innovation, the Omnipod 5 Automated Insulin Delivery System, integrates with a continuous glucose monitor to manage blood sugar with no multiple daily injections, zero fingersticks, and can be controlled by a compatible personal smartphone in the U.S. or by the Omnipod 5 Controller. Omnipod products are offered in 25 countries around the globe. HIRING SCAM ALERT Recently, individuals impersonating Insulet Human Resources members have offered fraudulent interviews and job offers to unsuspecting candidates. To help protect you from these scam artists, please be aware that: • Insulet will never interview a candidate over RingCentral, similar messaging apps or social media (i.e. Google Hangouts, WhatsApp, Facebook Messenger, etc.), or via text message. • Insulet will never send a company check or ask an applicant to pay a fee or purchase at home work/training materials in connection with an application for employment. • Insulet will never provide excess money to an applicant and ask the applicant to write a check for repayment. If you have any doubt about a job offer or any other communication purporting to come from Insulet, please reach out to us directly at 978-600-7000. If you receive any type of communication on behalf of Insulet that seems inappropriate or suspicious, please report this activity to: www.iC3.gov or www.stopfraud.gov.
- Website
-
http://www.insulet.com/
External link for Insulet Corporation
- Industry
- Medical Equipment Manufacturing
- Company size
- 1,001-5,000 employees
- Headquarters
- Acton, Massachusetts
- Type
- Public Company
- Founded
- 2000
- Specialties
- Medical Devices, Diabetic Management, Biotechnology, Medical Supply, Advanced Manufacturing, and Medical Supply Chain
Locations
-
Primary
100 Nagog Park
Acton, Massachusetts 01720, US
-
1 King Street
London, England, GB
-
1540 Cornwall Road
Suite 201
Oakville, Ontario L6J 7W5, CA
-
9276 Scranton Rd
San Diego, California 92121, US
Employees at Insulet Corporation
Updates
-
Insulet is proud to sponsor this week’s European Association for the Study of Diabetes e.V. (EASD) Annual Meeting in Vienna. This global event brings together more than 15,000 attendees from over 100 countries to exchange knowledge and discover the latest advancements in diabetes innovation. Our team is excited to welcome attendees to the Insulet booth in Hall B, where interactive experiences will showcase Omnipod® 5. In addition to booth activities, our team is hosting daily Oral Presentations on the clinical evidence and real-world outcomes from our RADIANT trials. If you’re attending the show, be sure to join us on Tuesday September 16 at 11:30 CET in Hall A when Dr. Pratik Choudhary and Dr. med. Sandra Schlüter take the 360° stage in the EASD Arena. Their session, “Disrupting Diabetes Care: Reimagine Your Clinical Practice to Save Time and Lives with Omnipod® 5,” will share real-world experiences and practical insights into how Omnipod® 5 is impacting care for people with diabetes. #TeamInsulet
-
-
At Insulet, we’re proud of our amazing team members who dedicate their time and talents to support the diabetes community in meaningful ways. In Atlanta, Georgia, Insulet’s U.S. Field Team joined the fun at Camp Kudzu. The Camp hosts three week-long overnight summer camp sessions for children ages 8–18. During summer sessions, campers enjoy a wide variety of traditional camp activities with diabetes education integrated throughout each day. Team members Bethany Harris, Jonathan Clarke, Amy Hicks, and Jami Lynn Phillips supported camp activities with medical supervision and taught campers new diabetes management skills and lessons. This helps campers gain a sense of community and independence as they learn and have fun with other children who have type 1 diabetes. #TeamInsulet
-
-
We are proud to be named to Newsweek’s list of America’s Greatest Companies 2025. Insulet was ranked among the top companies in the Medical Instruments and Supplies category for both innovation and impact. Newsweek highlighted the breakthrough design of our Omnipod® 5 product, positive patient survey feedback, and our unique approach to marketing. Learn more: https://lnkd.in/dyD3cMHE #TeamInsulet
-
-
Insulet is deeply honored to have received the Pro Patria Award at the recent Employer Support of the Guard & Reserve (ESGR) Award Ceremony, held at the Concord Museum and Armory in Concord, MA. The Pro Patria Award is presented annually by each ESGR State Committee to one small, one large, and one public sector employer that has demonstrated outstanding support for Guard and Reserve employees. Honorees are recognized for leadership and practices that include adopting personnel policies that make it easier for employees to serve in the National Guard and Reserve. Special thanks to Team Insulet member and Army National Guard Member Joseph C. as well as Scott Wright and Jack Kapples of Insulet’s Veterans and First Responders ERG for accepting the Award on behalf of our Company. #TeamInsulet
-
-
Join us in congratulating Aaron Rideout on his 10th work anniversary! Aaron began his career at Insulet in 2015 as Senior Regional Business Manager, serving our customers in Western Canada. Today, he is Sr. Director, Global Selling & Clinical Training, based in British Columbia. Thank you, Aaron, for your dedication and contributions. We’re grateful to have you on Team Insulet!
-
Omnipod® 5 users in Italy have enjoyed the benefits of automated insulin delivery with Abbott’s FreeStyle Libre 2 Plus and Dexcom G6 CGM sensors. Now they have even more sensor choices with the Dexcom G7 integration. Bravo! #TeamInsulet
-
-
Team Insulet spans the globe with dedicated professionals who embody our values every single day. Georgia Capeling, Senior Territory Manager for Northern England, sees this commitment firsthand in her region. "We have such a fantastic team, that really works hard every day, to deliver our mission." Watch the video to discover what inspires Georgia and drives Insulet’s excellence for over two and a half decades. #TeamInsulet
-
Insulet’s Global Downstream Medical Affairs team recently joined forces to support The Switch, an educational charity serving the community of Tower Hamlets in London. More than 20 employees gathered in our London office to assemble activity packs designed to provide meaningful educational experiences that raise aspirations and boost career opportunities for young people across the U.K. "To be able to provide hands-on materials for young people to hopefully inspire the next generation of innovators was incredibly valuable for our team and we encourage others at Insulet to join us in helping causes in their own communities," said Medical Affairs Manager, Brenda Ferris MS, RD, CDCES. #TeamInsulet
-
-
We’re excited to share that Amit Guliani has been appointed Chief Technology Officer, after his successful tenure as Acting CTO. Since joining Insulet in 2023, Amit has been an impactful leader—strengthening our engineering organization, enhancing customer experience, and helping to further launch Omnipod® 5 globally. As Insulet’s CTO, Amit will lead the development and implementation of scalable technology platforms to support Insulet’s rapid growth. Amit and his team will also advance critical AI and digital capabilities to help us operate more effectively and deliver superior, personalized digital experiences for our customers. Join us in congratulating Amit on this well-deserved promotion. #TeamInsulet #Innovation #Leadership
-